Purpose The purpose of this study was to develop and validate a new comprehensive patient-reported measure of treatment burden-the Patient Experience with Treatment and Self-management (PETS). Methods A conceptual framework was used to derive the PETS with items reviewed and cognitively tested with patients. A survey battery, including a pilot version of the PETS, was mailed to 838 multi-morbid patients from two healthcare institutions for validation. Results A total of 332 multi-morbid patients returned completed surveys. Diagnostics supported deletion and consolidation of some items and domains. Confirmatory factor analysis supported a domain model for scaling comprised of 9 factors: medical information, medications, medical appointments, monitoring health, interpersonal challenges, medical/healthcare expenses, difficulty with healthcare services, role/social activity limitations, and physical/mental exhaustion. Scales showed good internal consistency (a range 0.79-0.95). Higher PETS scores, indicative of greater treatment burden, were correlated with more distress, less satisfaction with medications, lower self-efficacy, worse physical and mental health, and lower convenience of healthcare (Ps \ 0.001). Patients with lower health literacy, less adherence to medications, and more financial difficulties reported higher PETS scores (Ps \ 0.01). Conclusion A comprehensive patient-reported measure of treatment burden can help to better characterize the impact of treatment and self-management burden on patient wellbeing and guide care toward minimally disruptive medicine.
Introduction
Treatment burden refers to the personal workload of healthcare, including treatment and self-management of chronic health conditions, and the impact of this workload on patient functioning and well-being [1] [2] [3] . Workload identifies the activities that patients are asked or required to do in order to care for their health (e.g., taking medications, maintaining medical appointments, monitoring health status, engaging in physical therapy). Impact refers to a patient's perception of the effect of the workload on role, social, physical, and psychological functioning. Financial challenges, confusion about medical information, and challenges with the healthcare system may add to the weight of the burden that is felt by the patient [2] [3] [4] [5] [6] . High treatment burden is an important clinical issue as evidence suggests that it may negatively affect behavioral and clinical outcomes such as adherence [7] [8] [9] [10] [11] . Non-adherence to medical regimens can lead to more hospitalization and readmissions, higher overall healthcare costs, and lower survival rates [12] [13] [14] [15] . Clinicians' response to poor patient outcomes is often to intensify treatment, which ostensibly reinforces and adds to the existing burden [16] . Not surprisingly, burdened patients also report poor quality of life [17] [18] [19] [20] .
People with multiple chronic conditions may be especially vulnerable to treatment burden. One in four American adults have multiple chronic conditions, with the prevalence expected to rise by [1 % per year until 2030 [21] [22] [23] [24] . Many are required to engage in a complex variety of medical and self-management activities just to maintain their health status at a given level [16, 25] . They are often required to seek care from a variety of providers which can lead to care that is fragmented, poorly coordinated [26] [27] [28] , complex, and straining on personal resources [16, 29] . To date, there are limited means of assessing patients' ability to integrate complex care into their lives. It is against this backdrop that we develop a comprehensive measure of treatment burden.
In this report, we describe the development and initial validation of the Patient Experience with Treatment and Self-management (PETS), a comprehensive, patient-reported measure of treatment burden. The measure is informed by a previously generated conceptual measurement framework based largely on qualitative data from patients with multiple chronic conditions (see Eton et al. 2015 ) [3] .
Drafting the measure
The PETS measure was drafted from the previously articulated conceptual framework [3] and then reviewed by a stakeholder panel consisting of physicians, health services researchers, patient advocates, and a nurse practitioner. After revision based on feedback from the panel, a new draft was submitted to cognitive pretesting with patients with multiple chronic conditions. A complete description of this developmental process can be found in a supplement to this report (see Online Resource Supplement 1). The resulting 78-item PETS measure submitted to validation consisted of the following fifteen content domains (and number of items within each): learning about health conditions and care (3), medications (5), difficulty with taking medications (6) , medical appointments (6), monitoring health (2) , exercise or physical therapy (5), diet (4), medical equipment (3), interpersonal challenges (4), medical/ healthcare expenses (8) , confusion/concern about medical information (6) , healthcare providers (7), difficulty with healthcare services (7), role and social activity limitations (6) , and physical/mental exhaustion (6) . Items use either a 4-or 5-point ordered, categorical response scale depending on content domain (e.g., very easy to very difficult, not at all to very much, strongly agree to strongly disagree, never to always).
Validation of the PETS measure Sample
The study sample was obtained from two clinical sites: the Hennepin County Medical Center (HCMC, Minneapolis, MN) and the Mayo Clinic (Rochester, MN). HCMC is a public ''safety net'' hospital located in urban Minneapolis that provides care for low-income, uninsured, and vulnerable persons. The Mayo Clinic is a multi-specialty integrated practice in southeastern Minnesota. Recruitment from both sites contributed to increased diversity of study participants. In selecting the sample for initial validation, we assumed that patients with (a) more chronic conditions and (b) more recent encounters with their healthcare provider(s) for these conditions were more likely to be experiencing treatment burden. Hence, patients meeting the following criteria were eligible: (1) C21 years old, (2) assigned to a primary care provider at either the Mayo Clinic or HCMC, (3) medical record-confirmed diagnoses of two or more chronic conditions (specifically conditions likely to require burdensome treatment and/or self-management strategies [27, [30] [31] [32] ) with these diagnoses listed on billing encounters of the past 3 years, and (4) at least one medical record-confirmed encounter with a Mayo Clinic or HCMC provider within the past 18 months for one or more of the selected chronic conditions. Patients lacking English language proficiency were excluded. The sampling frame was stratified based on number of diagnosed conditions (2, 3, or 4?), number of encounters with a provider within the past 18 months (1-8, 9-17, 18?), and age (\65 or C65). This resulted in eighteen strata from which patients were equally sampled across the two clinical sites.
Procedure
A self-administered, paper-and-pencil formatted survey battery was produced by the Mayo Clinic Survey Research Center. The battery consisted of the 78-item PETS measure as well as several established scales, including a 5-item chronic condition distress scale adapted from the diabetes distress scale [33] and specified generally for ''health problems'' (L. Fisher, personal communication), the 5-item side effects and 3-item convenience subscales of the Treatment Satisfaction Questionnaire for Medication (TSQM) [34] , the 8-item Perceived Medical Condition Self-Management scale (PMCSM), a general dispositional measure of self-efficacy or perceived competence in managing one's health condition [35] , and the PatientReported Outcomes Measurement Information System (PROMIS) Global-10 featuring global physical health (GPH) and global mental health (GMH) summary scores [36] . All are reliable and valid measures in patients with chronic illnesses [33, 34, 36, 37] . Demographic characteristics (age, race/ethnicity, education, and occupational status), personal health-related issues (i.e., numbers of prescription medications, perceived economic hardship due to medical care), and several other health-relevant concepts (i.e., health literacy, medication adherence, and convenience of healthcare services) [38] [39] [40] were assessed using targeted single items. Gender, number and types of chronic conditions, and number of recent encounters with a provider (last 18 months) were extracted from the electronic medical record.
Mailings prepared by each site included the survey battery, a cover letter, a small gift to encourage participation (designer pen or $3 gift card), and a stamped return envelope. Signed consent and privacy authorization were not required as the study was approved as exempt by both the Mayo and HCMC Institutional Review Boards. A total of 838 surveys were mailed based on the stratified random samples generated and expected minimum return rate of 40-50 %. To maximize returns, a second mailing to non-respondents occurred three weeks later.
Analyses

Item diagnostics
Prior to scaling analyses (i.e., factor analysis), item responses were first reviewed for missing data. Items with extensive amounts of missing data (C25 %) were set aside as low sample sizes can create unstable factor structures. Next, the inter-item correlation matrix of all PETS items (78 9 78) was examined to determine possible withindomain item redundancies and indicate items that might lack conceptual fit to their initially hypothesized domain. Possible item redundancies within a domain were flagged by an item-to-item correlation magnitude suggestive of content overlap (Spearman q C0.80). These items were candidates for exclusion. Items showing equivalent or higher cross-domain than within-domain item correlations were inspected for possible deletion or re-mapping prior to factor analysis.
Factor structure
After reviewing the item diagnostics, a set of competing confirmatory factor analyses (CFAs) were performed iteratively. The CFAs were performed using MPLUS version 7.2 [41] with the implementation of polychoric correlation matrices and weighted least squares with adjustments for mean and variance (WLSMV) estimation, which is appropriate for the evaluation of ordered categorical data. The initially hypothesized factor structure was the domain conceptual framework slightly modified by the results of the item diagnostics review. Subsequent models tested more parsimonious solutions (i.e., fewer factors). Several indices were used to establish the fit of the models to the data, including the comparative fit index (CFI [ 0.9 indicating good fit), Tucker-Lewis index (TLI [ 0.95 indicating good fit), and the root-mean-square error of approximation (RMSEA \ 0.10 desirable) [42, 43] . Results were used to test whether domain scoring by the conceptual framework could be justified or whether a simpler model is more appropriate.
Scoring of the PETS
All PETS scales were scored such that a higher score indicates greater treatment burden; thus, positively worded items were reverse-coded before scoring. Following this, raw scale scores were generated by summing the unweighted items within each factor supported by CFA. Given that some items will query issues that may not be applicable to all respondents, aggregated scale scores were prorated for missing item data, provided that at least 50 % of the total number of items in a scale were non-missing (e.g., 2 of 3 items, 3 of 5 items). Prorating in this manner has been used with other patient-reported measures [44] . To further facilitate interpretation, each raw scale score was transformed to a standardized 0-100 scale using the following formula: [((raw score -lowest possible raw score)/possible raw score range) 9 100].
Reliability and validity
Internal consistency reliability was computed for all PETS scales using Cronbach's a, with as C0.70 indicating adequate reliability [45] . Construct validity was determined by correlating PETS domain scores with scores from established measures of conceptually related constructs (i.e., convergence). For these analyses, we hypothesized that higher PETS scores would be associated with greater chronic condition distress (Chronic Condition Distress scale), greater bother of medication side effects (TSQM side effects), less medication convenience (TSQM convenience), lower self-efficacy for managing chronic illness (PMCSM), poorer overall physical and mental health (PROMIS-10), and lower convenience of healthcare services. A correlation magnitude of at least moderate level (Spearman q C0.30) and in the hypothesized direction would represent evidence of construct validity [46] . Validity was also determined by correlating PETS scores with data extracted from the medical record including, number of chronic conditions, and number of recent encounters with healthcare providers. We hypothesized that higher PETS scores would be associated with having more diagnosed conditions and more recent encounters with medical providers. Finally, known-groups validity was evaluated by comparing group means using independent samples t-tests. In comparing known groups, we hypothesized that patients who self-reported lower health literacy, less adherence to prescribed medications, and more financial difficulties due to their physical condition/ medical care would have higher PETS scores. Given the large number of analyses, a relatively conservative a level of 0.01 was set for all correlations and group comparisons. Analyses were performed in IBM SPSS Statistics version 20 Ò .
Results
Characteristics of the sample
Of 838 mailed surveys, 332 were completed and returned (40 % response). Demographic, medical, and other healthrelated characteristics of the sample are shown in Table 1 . There were slightly more female (56 %) than male participants, with a mean age of 66 years (range 26-90). The majority of respondents identified themselves as white (73 %), were married or living with a partner (58 %), and had at least some formal college or university education (70 %). Among variables extracted from the electronic medical record, the median number of diagnosed conditions was 3 and the median number of encounters with a medical provider in the past 18 months was 13.5. The most common diagnoses were hypertension (77 %), lipid metabolic disorders (76 %), diabetes (36 %), osteoarthritis (36 %), and coronary artery disease (19 %).
To test for possible responder bias, we assessed whether survey respondents were different from non-respondents by comparing frequency distributions of number of conditions (2, 3, 4?), number of encounters (1-8, 9-17, 18?), gender (female and male), and age (\65 and C65), variables that were all obtained from the medical record. There were no significant differences between responders and non-responders in the number of diagnosed conditions (v 2 (2) = 1.94, P = 0.47). However, the percentage of responders who had only 1-8 encounters with a provider in the last 18 months (32 %) was lower than the percentage of non-responders (42 %) with this number of encounters (v 2 (2) = 9.34, P = 0.009). Furthermore, the percentage of responders who were female (56 %) was greater than the percentage of non-responders who were female (46 %) (v 2 (1) = 7.51, P = 0.006), and the percentage of responders who were C65 years of age (57 %) was greater than the percentage of non-responders who were C65 years of age (46 %) (v 2 (1) = 9.66, P = 0.002).
Item diagnostics
Of the 78 items in the draft PETS measure, three items were removed due to extensive missing data (i.e., at least 25 % missing), including one item each from the difficulty with taking medications, medical/healthcare expenses, and confusion/concern about medical information domains. The majority of inter-item correlations (60 %) in the full 78 9 78 item correlation matrix were q C0.30 (a mediumsized correlation) [46] . Four more items were removed from the draft measure due to high inter-correlation(s) (q C 0.80) with at least one other item and a subsequent judgment of content overlap among those items, including one item each from the difficulty with taking medications, medical/healthcare expenses, confusion/concern about medical information, and physical/mental exhaustion domains. We also removed the seven items of the healthcare provider domain due to lack of conceptual fit with the treatment burden construct. Positive interpersonal qualities of one's provider are better construed as features that might lessen treatment burden, rather than contribute to it (see [47] ). Finally, one other item was removed due to equally high inter-item correlations with two different domains (medical/healthcare expenses and confusion about medical information); hence, it could not easily be mapped to a single domain. The excluded items and full results can be found in Online Resource Supplement 2. All items in the exercise/physical therapy, diet, and medical equipment domains had substantial amounts of missing data (46-61 %) due to skip patterns based on preceding yes/no screening questions and thus were excluded from the CFA. Furthermore, after deliberation, three items addressing barriers to medical appointments with low correlations with other items within the medical appointments domain were also excluded from CFA due to lack of conceptual fit. Thus, 48 items were retained from the PETS measure for subsequent testing. See Online Resource Supplement 2 for a record of all item diagnostics results.
Factor analysis and scaling of the PETS
The first CFA model tested featured 11 content domains and was based on the previously outlined conceptual framework [3] with some modification after review of item diagnostics (see above). Domains included learning about health conditions and care, medications, difficulty with taking medications, medical appointments, monitoring health, interpersonal challenges, medical/healthcare expenses, confusion/concern about medical information, difficulty with healthcare services, role/social activity limitations due to self-care, and physical/mental exhaustion due to self-care. This model assumed correlations of all factors, an assumption justified by the large degree of intercorrelation among all items (see above). The 11-factor correlated model provided a satisfactory fit to the data (CFI = 0.98, TLI = 0.97, RMSEA = 0.043, 90 % CI [0.039, 0.046]). Estimated correlations between the factors appear in Table 2 .
After review of the domain inter-correlations as well as the item content of each domain, a slightly modified factor structure was proposed. To obtain greater parsimony, we combined domains that were highly correlated (rs C 0.70) and deemed by us to have similar item content. Based on this rationale, the ''learning about health conditions/care'' and ''confusion/concern about medical information'' domains were combined into a single domain labeled, ''medical information.'' Further, the ''medications'' and ''difficulty with taking medications'' domains were consolidated into a single ''medications'' domain. Two items indicative of distress with taking medications-bother due to reliance on medicines and bother due to side effects of medicines-were analyzed separately. These two items assessing psychological bother appear to be conceptually distinct from the other seven items within the medications domain that assess the behavioral ease with which medications are taken and integrated into everyday life. The resulting 9-factor model featuring 46 items (less the two bother items) was subjected to CFA, which provided a satisfactory fit to the data (CFI = 0.98, TLI = 0.97, RMSEA = 0.045, 90 % CI [0.041, 0.049]). For comparative purposes, a one-factor model was also tested (all items loading on a single domain). This model provided a suboptimal fit to the data (CFI = 0.84, TLI = 0.84, RMSEA = 0.106, 90 % CI [0.103, 0.108]). Hence, nine multi-item scales (46 items total) were generated using the prorated, standardized scoring as defined above. The two medication bother items were retained with scores standardized to the 0-100 scale. Both were analyzed separately as single-item indicators in the subsequent validation analyses. The multi-item scales represented the following domains: medical information, medications, medical appointments, monitoring health, interpersonal challenges, medical/healthcare expenses, difficulty with healthcare services, role/social activity limitations, and physical/mental exhaustion. Mean scores, score ranges obtained, percentage scoring at floor (lowest possible burden score) and ceiling (highest possible burden score), and the skewness statistics for the total and site-specific samples are shown in Table 3 . Mean burden scores were generally higher in the HCMC patients than in the Mayo Clinic patients. Overall, scale scores were positively skewed toward lower burden, with the medications, medical appointments, interpersonal challenges, and role/social activity limitations scales showing greatest skewness and the most floor effects. The 48-item version of the PETS can be found in the Appendix.
Reliability
As shown in Table 4 , all nine multi-item scales showed good internal consistency reliability. Cronbach's a coefficients were well above threshold for adequate reliability (a C 0.70) [45] .
Construct and known-groups validity
As indicated in Table 4 , all nine PETS scales were significantly correlated with scores of conceptually related constructs assessed in established measures. Higher PETS scores (i.e., more burden) were associated with greater chronic condition distress (Chronic Condition Distress scale), more bother due to medication side effects (TSQM side effects), less medication convenience (TSQM convenience), lower self-efficacy for managing chronic illness (PMCSM), poorer physical and mental health (PROMIS-10), and lower patient-rated convenience of healthcare services. Magnitudes of most of these correlations (81 %) were of medium size or were greater (q C 0.30) [46] supporting construct validity of the PETS scales. PETS scores were largely uncorrelated with patient data extracted from the medical record. While having more diagnosed conditions was associated with more problems with medical/healthcare expenses (q = 0.15) and having more documented encounters with providers was associated with more medication problems (q = 0.25), more role/social activity limitations (q = 0.15), and more physical/mental exhaustion due to self-care (q = 0.19), these correlations were relatively small in magnitude. No other correlations Table 2 Confirmatory factor analytic-generated correlations of all 11 initially proposed content domains between these medical record variables and PETS scale scores were significant. Mean PETS scale scores were also compared across distinct patient groups (i.e., known-groups validity). As shown in Fig. 1 , patients who have difficulty reading and understanding written medical information (i.e., lower health literacy) reported significantly more treatment burden in 8 of 9 PETS domains compared to those without such difficulty.
Furthermore, compared to those who reported 100 % adherence to medications prescribed by their doctor(s), those adhering to medications B80 % of the time reported significantly more treatment burden in 8 of 9 PETS domains (see Fig. 2 ).
Finally, compared to patients indicating no or only ''a little'' financial difficulty due to their medical treatment or physical condition, those indicating financial difficulty ''somewhat'' or more reported significantly greater treatment burden in all PETS domains (see Fig. 3 ).
Validation analyses were also performed on the two single-item indicators of medication bother-bother due to reliance on medicines and bother due to side effects of medicines. Greater bother due to reliance on medicines was significantly correlated with more chronic condition distress (q = 0.42), less convenience of medication (q = -0.31), lower self-efficacy (q = -0.32), and poorer overall physical (q = -0.40) and mental health (q = -0.37) (all Ps \ 0.001). Greater bother due to medication side effects was also significantly correlated with more chronic condition distress (q = 0.40), less convenience of medication (q = -0.33), lower self-efficacy (q = -0.32), and poorer overall physical (q = -0.27) and mental health (q = -0.28) (all Ps \ 0.001). Both bother items were correlated with the number of prescription medications being taken (qs = 0.16, Ps \ 0.005); however, neither item was correlated with the number of diagnosed conditions (qs B 0.02).
Discussion
Substantial burden arises from the complexity of treatment regimens, including the self-management that is often required of patients to maintain health and avoid disease progression. This is especially true for those who must manage multiple chronic health conditions. With its potential to negatively impact clinical outcomes like adherence, treatment burden would seem an important issue to understand and assess. In this study, we describe the development and validation of the Patient Experience with Treatment and Self-management (PETS), a comprehensive measure of treatment burden that operationalizes issues previously outlined in a patient-informed conceptual framework of general treatment burden (i.e., non-condition specific). Content and face validity of the PETS were ascertained through a review by key stakeholders and patient cognitive interviews. A cross-sectional survey of 332 people with multiple chronic conditions provides initial evidence of the measure's reliability, construct validity, and ability to detect differences in meaningful groups of patients. Furthermore, the PETS appears to provide information about the patient that cannot be gleaned from a review of the medical record. The PETS measure validated in this study contains 48 items, most of which (46) are organized into 9 content domains (see Appendix). Factor analyses supported the scoring of these domains into 9 multi-item scales. Two items indicative of medication bother (reliance and side effects) are scored as single-item indicators. For this initial validation, we chose to err on the side of having more domains (i.e., scores) that are clinically meaningful and easy to interpret. Future studies will evaluate the replicability of the current model and investigate the viability of additional scoring algorithms that consolidate the domains into aggregated dimensions. Dimensional or ''component'' scoring can be a useful means of summarizing the health or well-being status of a population and is utilized in other well-established measures like the SF-36 and PROMIS Global-10 [36, 48] . The inter-correlations of the domains (see Table 2 ) would appear to justify further investigation of dimensional scoring. We chose to set aside several items and domains for later analysis and scrutiny. Items in the exercise/physical therapy, diet, and medical equipment content domains were each preceded by a screening question that invoked a skip pattern. Hence, there was a considerable amount of data missing for these items. We also set aside three items addressing barriers to getting to medical appointments. These items were less well correlated with the other items in the medical appointments domain. One or more of these items may be retained in future tests.
Clinical utility of the PETS could be considerable and remains to be assessed in future trials. Clinicians tend to know little about the burden that their recommendations place upon their patients, and how this burden might result in lesser adherence, attendance at visits, and poorer outcomes. We believe that a clinically oriented scale of treatment burden would be an impressive adjunct to clinical care and could guide clinicians and patients into joint discussions about the usefulness of recommendations and prioritizing of best next steps to take together. The lack of correlation with objective information from the medical record (i.e., numbers of conditions and provider visits) would seem to indicate that treatment burden is a subjective experience ideally assessed by patient self-report.
Finally, it is noteworthy that the term ''burden'' does not appear anywhere within the measure itself (including the name). During our initial qualitative exploration of the concept, some patients felt that this term had too negative a connotation, implying that a respondent is somehow failing or does not have the requisite skill to accomplish certain critical tasks. Others identified self-management simply as ''the work I have to do'' [47] . Hence, we felt it appropriate to remove any references to ''burden'' in the measure. To further diminish any perception of negative tone, for some content domains we opted to use balanced ''agree/ disagree'' or ''easy/difficult'' response scales, in lieu of always assessing the frequency of ''a problem.''
Limitations
Validation of a self-report measure does not occur in a single study; rather, it is a process that unfolds over time as psychometric evidence accumulates. While this study provides initial evidence of the PETS' reliability and validity in a diverse patient sample, its cross-sectional design is a limitation. We are currently undertaking a largescale, prospective validation study of the PETS to determine among other things its responsiveness to change, predictive validity, test-retest reliability, replicability of its factor structure, and viability of alternative scoring algorithms. This will be particularly important to determine as some of the PETS domain scales yielded scores that were somewhat positively skewed toward the favorable end (i.e., less burden) with substantial numbers scoring at the floor. While it is not unusual to observe such skewness in scores of patient-reported measures of health concepts [49] , it will be important to determine in future tests whether any skewness of PETS domain scores compromises the ability to detect change in patient status. Finally, as this study was conducted in the USA, it is possible that some issues represented in the PETS may be less relevant to patients of other global healthcare systems. For instance, medical and healthcare expenses may be of less concern to people residing in countries with government-subsidized healthcare systems. 
Conclusion
While self-report measures of treatment burden exist, current measures target specific diseases [19, 50] , treatment modes [17, 51] , circumscribed aspects of burden like perceived task difficulty [18] , or are lacking in comprehensiveness [52] . Developing measurement that comprehensively assesses the many domains of treatment burden that can be applied across chronic conditions or with multiple chronic conditions is still in its infancy. We believe that such a measure would have great value. First, it could provide a novel, patient-centered outcome for comparative effectiveness studies [53, 54] and epidemiologic and health services research designed to identify subgroups of patients at risk of poor outcomes [55] . Second, it could be used as a performance measure for healthcare entities or help evaluate innovative healthcare delivery models like patient-centered medical homes, nurse-coordinated care, or self-management support [56] [57] [58] [59] . Third, healthcare providers could use information on treatment burden to identify patients who may have problems with adherence to medical regimens or who are overwhelmed and may benefit from a more minimally disruptive medicine [16] . We are currently undertaking work with the PETS in all three of these areas, including construction of shorter versions of the measure. The breadth and richness of the measure will allow for comparisons across a wide variety of healthcare settings and patient conditions. As there is no calculated total score, users may choose to use only those PETS scales that are suited to their study or clinical setting. 
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